Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study of MSA-01 in Patients With Multiple System Atrophy

NCT07446894 is registered in ClinicalTrials.gov with Tokyo University as lead sponsor.

NCT NCT07446894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07446894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study of MSA-01 in Patients With Multiple System Atrophy
Lead sponsor
Tokyo University
Phase
Phase 3
Overall status
Recruiting
Start date
February 9, 2026
Completion date
March 31, 2028
Enrollment
140 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy (msa)